Delivery Order SPE2DB25D3108-SPE2DB25FPDYH
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,728.17 on June 16, 2025, for the supply of Venclexta 100 mg tablets (120-count units). This competitively awarded, firm fixed-price contract carries an ultimate completion date of July 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Venclexta 100 mg tablets (120-count units) valued at $9,728.17, with a completion date of October 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a continuation of the company's pharmaceutical supply services to the federal government. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Venclexta 100 mg tablets (quantity: 120 units) under a firm fixed-price contract valued at $9,728.17. This is a non-set-aside competitive award with an ultimate completion date of August 20, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) under a firm fixed-price contract. The order is scheduled for completion by September 11, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This is an unset-aside, competitively awarded contract that reflects the contractor's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-unit bottles). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by October 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,728.17 for Venclexta 100 mg tablets (120-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and represents a routine pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $9,728.17 delivery order to AmerisourceBergen Drug Corp for Venclexta 100 mg tablets (120-count units) under a firm fixed-price contract. The order, issued on August 19, 2025, with completion targeted for September 10, 2025, represents a direct procurement of this specialized pharmaceutical product to support federal medical supply requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) valued at $9,728.17. This firm fixed-price delivery order, awarded on June 16, 2025, represents fulfillment under the company's larger pharmaceutical supply contract with DLA. The award was made through open competition with no set-aside designation, with ultimate completion scheduled for July 9, 2025. AmerisourceBergen will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Venclexta 100 mg tablets in quantities of 120 units, with a ceiling value of $9,728.17 and an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a pharmaceutical supply transaction supporting federal medical procurement needs. The work is to be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets in quantities of 120s. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The contract is scheduled for completion by September 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDYHDelivery Order
The Defense Logistics Agency awarded a $9,728.17 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Venclexta 100 mg tablets (120-count units). This is a firm fixed-price contract with an ultimate completion date of October 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contract is to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. That prime contract vehicle supports comprehensive pharmaceutical and medical supply needs across the Defense Health Agency and military healthcare systems globally. AmerisourceBergen's federal contracting demonstrates consistent capability in delivering a broad range of pharmaceutical products, including specialty medications and brand-name drugs, to support military and veteran healthcare operations through a flexible ordering mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 9/15/25 |